Special Issue "Recent Progress in Multiple Sclerosis"
Deadline for manuscript submissions: 30 November 2021.
Interests: multiple sclerosis; neuroimmunology; neurodegeneration; remyelination; neuroprotection
Interests: multiple sclerosis and neuromyelitis optica; neuroimaging; retinal optical coherence tomography; neuroprotection; dietary modulation of neuroinflammation
Multiple sclerosis is the most common disease that leads to neurological disability in young people. Despite the advances over the years in understanding the disease, more knowledge is needed about the specific mechanisms of the relapses versus progression independent of relapses, the immediate damage caused by the formation of a new lesion and the secondary damage induced over time due to the demyelination and axonal damage. Inflammatory activity is, on the one hand, harmful but may also be protective. The various approaches to inducing the repair of the damage caused and the development of various imaging and molecular paraclinical biomarkers that demonstrate different aspects of disease activity and progression and the degree of response to treatment are worthy of study. All of these and more represent a broad and intensive field of research that will expand our understanding of the disease and lead to exciting discoveries.
The objective of this Special Issue, “Recent Progress in Multiple Sclerosis”, is to describe and bring together the most recent research conducted in the fields of the pathophysiology, of various biomarkers, and the treatment and repair of multiple sclerosis.
Prof. Friedemann Paul
Dr. Arnon Karni
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- multiple sclerosis
- immune pathophysiology
- remyelination and repair
- molecular biomarker
- disease monitoring
- modifiable environmental factors